Moore Capital Management, LP Biogen Inc. Transaction History

Moore Capital Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $6.68 Million - $8.04 Million	30,000 Added 50.0%	90,000 $23.3 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $15.2 Million - $17.2 Million	60,000 New	60,000 $15.4 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $384,840 - $438,509	1,500 New	1,500 $417,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $2.08 Million - $2.87 Million	-10,684 Reduced 37.25%	17,995 $4.81 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $5.38 Million - $6.4 Million	28,679 New	28,679 $5.85 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $4.52 Million - $5.81 Million	-20,206 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $16.7 Million - $21.8 Million	-58,952 Reduced 74.47%	20,206 $5.72 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $20.5 Million - $32.8 Million	79,158 New	79,158 $27.4 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $2.67 Million - $3.38 Million	-9,924 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $2.18 Million - $3.02 Million	9,924 New	9,924 $2.95 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $7.32 Million - $11.5 Million	-33,792 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $9.41 Million - $11.9 Million	33,792 New	33,792 $10.2 Million

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.